Molecular characterization and prognostic analysis of non-small cell lung cancer: A single centric real-world study.

被引:0
|
作者
Zhang, Hongbin
Wang, Yuan
Ji, Qiaoxia
Cai, Hongmei
Liang, Xiangcun
Xie, Jiong
Li, Hua
Wang, Jun
Zhu, Guiyun
Tian, Erpeng
Zhu, Lingling
Yuan, Mingming
Wang, Kai
Chen, Rongrong
Zhao, Min
机构
[1] Hebei Chest Hosp, Dept Oncol, Res Ctr Hebei Lung Canc Prevent & Treatment, Shijiazhuang, Hebei, Peoples R China
[2] Hebei Med Univ, Dept Radiat Oncol, Hosp 4, Shijiazhuang, Hebei, Peoples R China
[3] Hebei Chest Hosp, Dept Pathol, Shijiazhuang, Hebei, Peoples R China
[4] Hebei Chest Hosp, Mol Biol Lab, Shijiazhuang, Hebei, Peoples R China
[5] Geneplus Beijing Ltd, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e21646
引用
收藏
页数:2
相关论文
共 50 条
  • [1] EGFR Exon 20 insertion: Prognostic and predictive values in advanced non-small cell lung cancer, a real-world study.
    Chouaid, Christos
    Filleron, Thomas
    Debieuvre, Didier
    Perol, Maurice
    Girard, Nicolas
    Dansin, Eric
    Gervais, Radj
    Cousin, Sophie
    Otto, Josiane
    Schott, Roland
    Planchard, David
    Madroszyk, Anne
    Kaderbhai, Coureche
    Dubray-Longeras, Pascale
    Hiret, Sandrine
    Pichon, Eric
    Clement-Duchene, Christelle Anne
    Martin, Anne-Laure
    Simon, Gaetane
    Quantin, Xavier
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Safety of pembrolizumab in patients with non-small cell lung cancer: a real-world study
    Thakrar, D. B.
    Essang, B.
    Echlin, A.
    Murdock, C.
    Lind, M. J.
    [J]. LUNG CANCER, 2019, 127 : S40 - S41
  • [3] A Real-World Study in Advanced Non-Small Cell Lung Cancer with KRAS Mutations
    Lei, Lei
    Wang, Wen-xian
    Yu, Zong-yang
    Liang, Xian-bin
    Pan, Wei-wei
    Chen, Hua-fei
    Wang, Li-ping
    Fang, Yong
    Wang, Min
    Xu, Chun-wei
    Fang, Mei-yu
    [J]. TRANSLATIONAL ONCOLOGY, 2020, 13 (02): : 329 - 335
  • [4] Lung Cancer Prognostic Index Performance in US Real-World Advanced Non-Small Cell Lung Cancer Patients
    Shah, R.
    John, A.
    Alexander, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S391 - S391
  • [5] Real-world prognostic value of RET fusions in advanced non-small cell lung cancer (aNSCLC)
    Gadgeel, S. M.
    Zhang, Q.
    Lin, H.
    Fajardo, O.
    Trinh, H.
    Arndorfer, S.
    Kong, S.
    Rahman, A.
    Li, S.
    Archer, V. R.
    Gainor, J. F.
    [J]. ANNALS OF ONCOLOGY, 2023, 34
  • [6] Radiotherapy with continued EGFR-TKIs for oligoprogressive disease in non-small cell lung cancer: A real-world study.
    Wu, Fang
    Wu, Sixuan
    Hu, Chunhong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] Prevalence, molecular characterization, and prognosis of METeoverexpressing non-small cell lung cancer (NSCLC) in a real-world patient cohort
    Bar, J.
    Cai, M. H.
    Choi, Y. C.
    Baijal, S.
    Zhao, W.
    Liede, A.
    Raskin, L.
    Vasilopoulos, A.
    Li, M.
    Roberts-Rapp, L.
    Jiang, F.
    Ratajczak, C.
    Lu, S.
    Ansell, P. J.
    Camidge, D. R.
    [J]. ANNALS OF ONCOLOGY, 2023, 34
  • [8] Comparison of clinical characteristics and prognoses of patients with T1 non-small cell lung cancer and small cell lung cancer in a Chinese real-world study.
    Xu Jinming
    Zhao, Heng
    Li, Xiaofei
    Liu, Yang
    Liu, Lunxu
    Fu, Xiangning
    Xu, Lin
    Li, Yin
    Han, Xingpeng
    Liu, Deruo
    Wu, Yihe
    Cao, Jinlin
    Yang, Haiying
    Hu, Jian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Real-World Analysis of the Impact of Radiotherapy on Immunotherapy Efficacy in Non-Small Cell Lung Cancer
    Onn, Amir
    Gottfried, Teodor
    Stemmer, Amos
    Appel, Sarit
    Lawrence, Yaacov R.
    Urban, Damien
    Beller, Tamar
    Daher, Sameh
    Bar, Jair
    [J]. CANCERS, 2021, 13 (11)
  • [10] REAL-WORLD COSTS OF LABORATORY TESTS FOR NON-SMALL CELL LUNG CANCER
    van der Linden, N.
    Smit, E. F.
    Uyl-De Groot, C. A.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A622 - A623